Supplemental Annuity Collective Trust (SACT) of New Jersey’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Hold |
11,000
| – | – | 0.1% | 174 |
|
|
2025
Q1 | $369K | Hold |
11,000
| – | – | 0.12% | 171 |
|
|
2024
Q4 | $431K | Hold |
11,000
| – | – | 0.13% | 164 |
|
|
2024
Q3 | $433K | Hold |
11,000
| – | – | 0.13% | 168 |
|
|
2024
Q2 | $429K | Hold |
11,000
| – | – | 0.13% | 159 |
|
|
2024
Q1 | $474K | Hold |
11,000
| – | – | 0.15% | 155 |
|
|
2023
Q4 | $507K | Hold |
11,000
| – | – | 0.18% | 138 |
|
|
2023
Q3 | $376K | Hold |
11,000
| – | – | 0.14% | 161 |
|
|
2023
Q2 | $424K | Hold |
11,000
| – | – | 0.15% | 155 |
|
|
2023
Q1 | $394K | Hold |
11,000
| – | – | 0.15% | 157 |
|
|
2022
Q4 | $434K | Hold |
11,000
| – | – | 0.18% | 149 |
|
|
2022
Q3 | $397K | Hold |
11,000
| – | – | 0.17% | 154 |
|
|
2022
Q2 | $335K | Hold |
11,000
| – | – | 0.13% | 173 |
|
|
2022
Q1 | $336K | Hold |
11,000
| – | – | 0.11% | 196 |
|
|
2021
Q4 | $344K | Hold |
11,000
| – | – | 0.11% | 194 |
|
|
2021
Q3 | $168K | Hold |
11,000
| – | – | 0.06% | 220 |
|
|
2021
Q2 | $205K | Hold |
11,000
| – | – | 0.07% | 216 |
|
|
2021
Q1 | $197K | Hold |
11,000
| – | – | 0.07% | 217 |
|
|
2020
Q4 | $169K | Hold |
11,000
| – | – | 0.06% | 211 |
|
|
2020
Q3 | $122K | Hold |
11,000
| – | – | 0.05% | 211 |
|
|
2020
Q2 | $138K | Hold |
11,000
| – | – | 0.06% | 210 |
|
|
2020
Q1 | $125K | Hold |
11,000
| – | – | 0.07% | 197 |
|
|
2019
Q4 | $144K | Hold |
11,000
| – | – | 0.06% | 225 |
|
|
2019
Q3 | $99K | Buy |
+11,000
| New | +$99K | 0.05% | 219 |
|